FI770160A - - Google Patents

Info

Publication number
FI770160A
FI770160A FI770160A FI770160A FI770160A FI 770160 A FI770160 A FI 770160A FI 770160 A FI770160 A FI 770160A FI 770160 A FI770160 A FI 770160A FI 770160 A FI770160 A FI 770160A
Authority
FI
Finland
Application number
FI770160A
Other languages
Finnish (fi)
Inventor
Klaus Hasspacher
Michael Strasser
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI770160A publication Critical patent/FI770160A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI770160A 1976-01-28 1977-01-19 FI770160A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH107176 1976-01-28
CH107076 1976-01-28

Publications (1)

Publication Number Publication Date
FI770160A true FI770160A (de) 1977-07-29

Family

ID=25686556

Family Applications (1)

Application Number Title Priority Date Filing Date
FI770160A FI770160A (de) 1976-01-28 1977-01-19

Country Status (12)

Country Link
US (1) US4094987A (de)
JP (1) JPS5293766A (de)
AU (1) AU2168677A (de)
DE (1) DE2701705A1 (de)
DK (1) DK20777A (de)
ES (1) ES455346A1 (de)
FI (1) FI770160A (de)
FR (1) FR2339598A1 (de)
IL (1) IL51334A0 (de)
NL (1) NL7700681A (de)
PT (1) PT66120A (de)
SE (1) SE7700606L (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU78625A1 (de) * 1977-12-02 1979-06-13 Byk Gulden Lomberg Chem Fab Substituierte 1-phenyl-2-pyrrolidin-2-yl-ethanole,verfahren zu ihrer herstellung,ihre verwendung und sie enthaltende arzneimittel
HU185422B (en) * 1979-12-05 1985-02-28 Astra Laekemedel Ab,Se Process for producing phenyl-azacycloalkanes
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5625060A (en) * 1991-05-03 1997-04-29 Elf Sanofi Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions on which they are present
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
WO2009014910A2 (en) 2007-07-19 2009-01-29 Metabolex, Inc. N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the rup3 or gpr119 receptor for the treatment of diabetes and metabolic disorders
AU2009271414A1 (en) * 2008-06-20 2010-01-21 Metabolex, Inc. Aryl GPR119 agonists and uses thereof
WO2011041154A1 (en) 2009-10-01 2011-04-07 Metabolex, Inc. Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
WO2011163090A1 (en) 2010-06-23 2011-12-29 Metabolex, Inc. Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
CN109862896A (zh) 2016-08-03 2019-06-07 西玛贝医药公司 用于治疗炎症性胃肠疾病或胃肠病症的氧亚甲基芳基化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1283452A (en) * 1970-07-24 1972-07-26 Parke Davis & Co Substituted 1,3-dialkylpyrrolidines and processes for their production

Also Published As

Publication number Publication date
ES455346A1 (es) 1978-12-01
IL51334A0 (en) 1977-03-31
DK20777A (da) 1977-07-29
DE2701705A1 (de) 1977-08-04
AU2168677A (en) 1978-08-03
FR2339598A1 (fr) 1977-08-26
US4094987A (en) 1978-06-13
JPS5293766A (en) 1977-08-06
NL7700681A (nl) 1977-08-01
SE7700606L (sv) 1977-07-29
PT66120A (fr) 1977-02-01

Similar Documents

Publication Publication Date Title
CS177741B1 (de)
DD123217A1 (de)
CH611496A5 (de)
BE859801A (de)
BG23029A1 (de)
BG23033A1 (de)
CH511976A4 (de)
CH512076A4 (de)
CH593420A5 (de)
CH594478A5 (de)
CH598867A5 (de)
CH598940A5 (de)
CH599772A5 (de)
CH601032A5 (de)
CH601059A5 (de)
CH601062A5 (de)
CH601544A5 (de)
CH601645A5 (de)
CH601666A5 (de)
CH602156A5 (de)
CH603399A5 (de)
CH605474A5 (de)
CH606475A5 (de)
CH606658A5 (de)
CH609140A5 (de)

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SANDOZ AG